New blood tests could help doctors diagnose Alzheimer’s disease faster and more accurately, researchers reported in July. But ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks to ...

However, the drugmaker's prospects look so strong that not only should it soon join the $1 trillion club, but it could even ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

The Florida-based provider will work with AI software company AiraMed to analyze and measure patients' brain volume from MRIs.

As the global population ages, the demand for healthcare services surges, making the sector a promising avenue for long-term ...

A report published Wednesday in The BMJ questioned the safety and effectiveness of the Alzheimer’s disease drug Kisunla ...

A woman from Chester Springs, Pennsylvania, is one of the first patients in the country to receive a new FDA-approved ...

A Montgomery County, Pennsylvania patient will be one of the country's first patients to receive a newly FDA-approved ...

Japan’s Ministry of Health, Labour and Welfare granted new drug approvals and expanded indications for conditions like cancer, insomnia and Alzheimer’s disease (AD) Sept. 24, including Eli Lilly and ...

Eli Lilly LLY announced that its Alzheimer's disease (AD) drug Kisunla (donanemab) has been approved for use in Japan. The ...

Nearly 75 people in 19 teams joined the Walk to End Alzheimer’s Saturday at Yanney Heritage Park and raised an unofficial ...